Readers Write: It’s Time for Drug Price Transparency

No comments

EHR vendors face a tough challenge in deciding which new features to develop and integrate for their next release and which ones to leave on the cutting room floor. The benefits of each potential enhancement must be weighed against the costs, usually measured in programming time. Moreover, features required for Meaningful Use and MIPS must be included, making the triage even more difficult.

popdevteamReaders Write: It’s Time for Drug Price Transparency